1.
Notification of the State Food and Drug Administration of the People's Republic of China, on Implementing the Record Checking Procedures in the re-registering application for Imported Drugs
国家食品药品监督管理局关于进口药品再注册申请实行核档程序的通告
2.
generic drug
不注册的药品,不受注册商标保护的药品
3.
Photocopy of the Drug Import Registration Certificate (or the copy of Pharmaceutical Product Registration Certificate) and photocopy of the Drug Import Approval;
《进口药品注册证》（或者《医药产品注册证》）复印件、《进口药品批件》复印件；
4.
Preliminary analysis of Requirements for On-site Verification for Drug Registration;
浅析《药品注册现场核查管理规定》
5.
New Problems in FDA Problems in Drug Registration
FDA药品注册管理过程中的几个新问题
6.
Improve the Registration of Pharmaceutical Packaging Materials for the Safety and Effect of Medicines;
完善药包材注册管理 保障药品安全有效
7.
Connecting and Perfecting the Regulations on Medical Patent Investigation and Registration;
药品专利审查和新药注册制度的链接与完善
8.
Article41] With the exception of Chinese medicinal materials and Chinese medicines sliced and prepared for decoction, drugs must use a registered trademark and may not be sold on the market until examined and approved for registration.
第四十一条除中药材、药饮片外，药品必须使用注册商标；未经核准注册的，不得在市场销售。
9.
An applicant forges or alters the relevant documents and vouchers; The Drug Import Registration Certificate (or the Pharmaceutical Registration Certificate) has been canceled;
伪造、变造有关文件和票据的；《进口药品注册证》（或者《医药产品注册证》）已被撤销的；
10.
The registered trade mark of the products is... Brand.
产品注册商标为..
11.
Comparison and Analysis of Registration Authorisation Regulation of Veterinary Biological and Drug Product in U.S.A, EU and China;
国内外兽医药品注册管理规定的比较分析
12.
Solving Patent Problem in the Registration and Approval of Drugs;
药品注册审批工作中专利相关问题探讨
13.
Discussion on the Intellectual Property Protection in the Drug Registration Regulations
浅谈《药品注册管理办法》中的知识产权保护
14.
Comparative Study on Chinese and American Procedures of Drug Registration
中、美药品注册管理法规体系的比较研究
15.
Requirement and Suggestion on Re-registration of Imported Veterinary Biologics
进口兽用生物制品再注册申报的要求及建议
16.
Its tasks should relate in particular to establishing Community herbal monographs relevant for the registration as well as the authorisation of herbal medicinal products.
其任务主要是建立适用于草药品注册和授权的共同体草药专论。
17.
The facilitated registration should be acceptable only where the herbal medicinal product may rely on a sufficiently long medicinal use in the Community.
（7）便利的注册应只接受那些在共同体内有长期临床应用的草药品。
18.
Collect and file all quality documents (i.e. DAR, IDL, Regulation, Product Information and etc.).
负责质量文件（如药检报告、注册证、法规、产品信息等）的收集、存档工作。